ESE, CADX, HLX are Biggest Small Cap Stocks Losers

If you are planning to invest money in stock market then you must subscribe to FREE Alerts by visiting: http://www.pennystockpickreport.com/

ESCO Technologies Inc. (NYSE:ESE) decreases 12.90% to $32.54 after Brean Murray gave the Scientific & Technical Instruments industry some bad news as it announced that the company was downgraded from Buy to Hold. ESCO Technologies Inc. is a producer of engineered products and systems sold to customers, primarily for utility, industrial and commercial applications.

Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) went down 7.85% to $8.80 after the company announced that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act goal date for its Priority Review of the New Drug Application for intravenous acetaminophen by three months. The extended PDUFA goal date is February 12, 2010. The FDA designated one of Cadence's submissions to the NDA, which contained additional clinical pharmacology data requested by the agency during the review process, as a major amendment.

Helix Energy Solutions Group Inc. (NYSE:HLX) plunges 4.68% to $13.44. The stock hit an intraday high and an intraday low of $14.13 and $13.24 respectively. In the last six months the stock went up over 42%. Helix Energy Solutions Group, Inc. is an international offshore energy company providing reservoir development solutions and other contracting services to the energy market, as well as to other oil and gas properties.

ABOUT PennyStockPickReport.com

 Penny Stock Pick Report is an independent electronic publication that provides information on selected publicly traded companies. Penny Stock Pick Report is not a registered investment advisor or broker-dealer. Penny Stock Pick Report affiliates, directors, officers, and employees may purchase and sell additional shares in any company which are mentioned above and may profit in the event those shares rise in value. Please do your research before you plan to invest in any of the stocks mentioned above.